Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics entities : Denali therapeutics inc. save search
Indivi to Collaborate with Biogen to Advance Digital Health Technology and Digital Biomarkers for Parkinson's Disease
Published: 2024-03-26 (Crawled : 19:00) - biospace.com/
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: 1.33%
H: 0.25%
C: -1.27%
disease parkinson's health technology biomarkers
Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024
Published: 2024-03-19 (Crawled : 12:30) - prnewswire.com
OMGA | $2.345 -1.88% -1.92% 300K
|
|
| O: 0.0%
H: 1.42%
C: -2.56%
SANA | $8.09 2.02% 1.98% 1.7M
|
|
| O: -1.57%
H: 1.48%
C: -1.37%
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: 0.22%
H: 12.36%
C: 6.11%
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: -0.35%
H: 1.59%
C: 1.16%
FHTX | $5.135 1.68% 1.66% 46K
|
Health Technology
|
| O: -1.01%
H: 5.45%
C: 3.41%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: -0.75%
H: 3.41%
C: 3.01%
companies
Amyotrophic Lateral Sclerosis Treatment Market size to grow by USD 663.7 million, 42% of market growth is expected in North America, Technavio
Published: 2024-03-12 (Crawled : 04:00) - prnewswire.com
ELDN | $2.15 6.44% 6.05% 190K
|
Manufacturing
|
| O: 1.73%
H: 1.7%
C: -7.39%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: -0.6%
H: 0.74%
C: -3.66%
BCLI A | $0.531 -1.69% -1.71% 170K
|
Health Technology
|
| O: -2.43%
H: 2.8%
C: -4.02%
BIIB | $193.18 -0.48% -0.48% 1.4M
|
Health Technology
|
| O: -0.32%
H: 0.18%
C: -0.86%
expected sclerosis treatment growth market
Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Published: 2024-02-27 (Crawled : 13:00) - globenewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: 18.06%
H: 17.95%
C: 17.1%
business year therapeutics financial results
Denali Therapeutics Announces $500 million Private Placement Equity Financing
Published: 2024-02-27 (Crawled : 13:00) - globenewswire.com
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: 18.06%
H: 17.95%
C: 17.1%
million therapeutics
Denali Therapeutics Announces New Data and Expansion of Its Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapy Programs at WORLDSymposium™
Published: 2024-02-07 (Crawled : 13:00) - globenewswire.com
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: -0.18%
H: 4.7%
C: 2.11%
expansion therapeutics therapy
Denali Therapeutics Announces Presentations on Its Investigational Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapies at the Upcoming 2024 WORLDSymposium™
Published: 2024-02-01 (Crawled : 13:00) - globenewswire.com
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: 0.94%
H: 1.79%
C: 1.42%
therapeutics
Denali Therapeutics Announces Key Anticipated 2024 Milestones and Priorities to Further Advance Its Therapeutics Portfolio for Neurodegeneration and Lysosomal Storage Diseases
Published: 2024-01-08 (Crawled : 13:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.07%
H: 0.48%
C: 0.48%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.16%
H: 0.0%
C: 0.0%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: -0.41%
H: 5.71%
C: 5.71%
key therapeutics
Sail Biomedicines Provides Update on Research with Cystic Fibrosis Foundation and Pioneering Medicines
Published: 2024-01-05 (Crawled : 17:00) - biospace.com/
OMGA | $2.345 -1.88% -1.92% 300K
|
|
| O: 1.41%
H: 0.37%
C: -18.55%
SANA | $8.09 2.02% 1.98% 1.7M
|
|
| O: 2.04%
H: 10.8%
C: 2.0%
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: 0.71%
H: 2.84%
C: -0.71%
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: -0.82%
H: 7.46%
C: 3.11%
FHTX | $5.135 1.68% 1.66% 46K
|
Health Technology
|
| O: -1.79%
H: 7.65%
C: 2.55%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: -2.47%
H: 0.66%
C: -2.18%
update fibrosis research
Alzheimer's Disease Therapeutics Market size to grow by USD 5.41 billion from 2023-2028; North America to account for 39% of market growth - Technavio
Published: 2023-12-12 (Crawled : 20:00) - prnewswire.com
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
|
| O: -10.21%
H: 0.0%
C: 0.0%
GIKLY | $4.4 132.75% 150
|
Manufacturing
|
| O: 2.92%
H: 0.0%
C: 0.0%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.71%
H: 0.88%
C: 0.85%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: -0.17%
H: 1.17%
C: 0.86%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: 2.9%
H: 8.82%
C: 8.56%
BIIB | $193.18 -0.48% -0.48% 1.4M
|
Health Technology
|
| O: 0.09%
H: 2.58%
C: 2.52%
america disease alzheimer's therapeutics growth market
Amyotrophic Lateral Sclerosis Treatment Market size to grow by USD 663.7 million from 2023 to 2028, North America to account for 42% of market growth - Technavio
Published: 2023-12-07 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.06%
H: 0.82%
C: 0.82%
ELDN | $2.15 6.44% 6.05% 190K
|
Manufacturing
|
| O: -1.59%
H: 7.26%
C: 2.42%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: -0.21%
H: 0.08%
C: -1.76%
BCLI A | $0.531 -1.69% -1.71% 170K
|
Health Technology
|
| O: 0.0%
H: 3.56%
C: -9.77%
BIIB | $193.18 -0.48% -0.48% 1.4M
|
Health Technology
|
| O: -0.61%
H: 1.33%
C: 0.69%
america sclerosis treatment growth market
Parkinson's Disease Therapeutics Market revenue to hit USD 12.32 Billion by 2033, Says We Market Research
Published: 2023-12-06 (Crawled : 15:30) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: 1.64%
H: 0.0%
C: -1.33%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.52%
H: 0.18%
C: -0.43%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: -0.03%
H: 0.28%
C: -0.41%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: 0.05%
H: 5.74%
C: 3.18%
BIIB | $193.18 -0.48% -0.48% 1.4M
|
Health Technology
|
| O: 0.42%
H: 2.37%
C: 1.45%
disease parkinson's revenue research therapeutics market
Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science Leaders
Published: 2023-11-28 (Crawled : 00:00) - prnewswire.com
OMGA | $2.345 -1.88% -1.92% 300K
|
|
| O: -1.07%
H: 2.15%
C: -1.62%
SANA | $8.09 2.02% 1.98% 1.7M
|
|
| O: -0.24%
H: 3.07%
C: 0.24%
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: -2.59%
H: 2.65%
C: 0.0%
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: -0.51%
H: 1.2%
C: 1.11%
FHTX | $5.135 1.68% 1.66% 46K
|
Health Technology
|
| O: -1.84%
H: 0.47%
C: -1.64%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: 0.17%
H: 2.23%
C: 1.95%
life
Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics
Published: 2023-11-21 (Crawled : 11:00) - prnewswire.com
OMGA | $2.345 -1.88% -1.92% 300K
|
|
| O: 0.0%
H: 2.99%
C: -4.5%
SANA | $8.09 2.02% 1.98% 1.7M
|
|
| O: -2.09%
H: 0.48%
C: -4.75%
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: 10.3%
H: 10.28%
C: -2.34%
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: -2.38%
H: 0.77%
C: 0.08%
FHTX | $5.135 1.68% 1.66% 46K
|
Health Technology
|
| O: 0.0%
H: 4.14%
C: 0.0%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: -2.34%
H: 0.0%
C: -2.83%
frontier therapeutics
Denali Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights
Published: 2023-11-07 (Crawled : 21:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.62%
H: 0.0%
C: 0.0%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: -5.61%
H: 4.24%
C: 0.7%
business therapeutics financial results
In-Depth Analysis of Mucopolysaccharidosis Market and its Subtypes: Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis III, Mucopolysaccharidosis IV, and Mucopolysaccharidosis VII | DelveInsight
Published: 2023-10-24 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.4%
H: 1.29%
C: 1.29%
VRTX | $404.93 1.25% 1.43% 1.1M
|
Health Technology
|
| O: -0.05%
H: 0.21%
C: -1.67%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.43%
H: 0.64%
C: -0.09%
RGNX | $15.885 1.57% 1.54% 360K
|
Health Technology
|
| O: -1.13%
H: 1.43%
C: -1.02%
EDIT | News | $5.465 -2.41% -2.47% 1.6M
|
Health Technology
|
| O: -1.07%
H: 4.0%
C: 1.85%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: -1.22%
H: 3.29%
C: 0.92%
BEAM | $23.46 -2.66% -2.73% 1.2M
|
Health Technology
|
| O: -1.33%
H: 1.82%
C: 0.36%
AGIO | $31.82 5.33% 5.06% 1.2M
|
Health Technology
|
| O: -0.76%
H: 0.58%
C: -2.79%
market
Flagship Pioneering Appoints John Lepore as CEO-Partner and CEO of ProFound Therapeutics
Published: 2023-10-02 (Crawled : 11:00) - prnewswire.com
OMGA | $2.345 -1.88% -1.92% 300K
|
|
| O: 4.65%
H: 0.0%
C: -16.0%
SANA | $8.09 2.02% 1.98% 1.7M
|
|
| O: -0.26%
H: 0.0%
C: -7.25%
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -9.66%
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: -0.16%
H: 0.91%
C: 0.18%
FHTX | $5.135 1.68% 1.66% 46K
|
Health Technology
|
| O: -1.0%
H: 0.83%
C: -10.3%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: -3.6%
ceo therapeutics
ProFound Therapeutics Expands Leadership Team With Appointment of Klaus Urbahns as Chief Scientific Officer
Published: 2023-09-25 (Crawled : 13:00) - biospace.com/
OMGA | $2.345 -1.88% -1.92% 300K
|
|
| O: 0.32%
H: 0.95%
C: -4.76%
SANA | $8.09 2.02% 1.98% 1.7M
|
|
| O: 3.92%
H: 2.01%
C: -1.26%
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: 0.0%
H: 1.53%
C: -7.66%
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: -0.47%
H: 0.28%
C: -1.36%
FHTX | $5.135 1.68% 1.66% 46K
|
Health Technology
|
| O: -1.16%
H: 3.68%
C: 2.51%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: -0.36%
H: 1.0%
C: -0.36%
therapeutics
Denali Therapeutics Announces New Interim Data from Phase 1/2 Study of DNL310 (ETV:IDS) in MPS II (Hunter Syndrome) at SSIEM 2023
Published: 2023-08-30 (Crawled : 13:00) - globenewswire.com
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: -0.22%
H: 1.92%
C: 1.92%
dnl310 therapeutics study
Flagship Pioneering Announces Appointment of David Khougazian as Growth Partner
Published: 2023-08-29 (Crawled : 12:00) - prnewswire.com
OMGA | $2.345 -1.88% -1.92% 300K
|
|
| O: 1.66%
H: 9.24%
C: 6.52%
SANA | $8.09 2.02% 1.98% 1.7M
|
|
| O: 0.0%
H: 1.07%
C: -2.35%
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: -0.56%
H: 1.84%
C: 0.56%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.34%
H: 0.0%
C: 0.0%
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: -0.07%
H: 2.36%
C: 1.97%
FHTX | $5.135 1.68% 1.66% 46K
|
Health Technology
|
| O: 0.0%
H: 3.05%
C: 2.79%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: 0.09%
H: 1.18%
C: 0.66%
growth
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.